Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice
J. Clin. Invest. Kathrin Stirnemann, et al. 118:994
doi:10.1172/JCI33249 [Go to this article.]

Problems with a PDF?

Copyright © 2008 by the American Society for Clinical Investigation.
Copying, redistribution, and other usage policies